Royalty Pharma Sub-Manager, LLC
Holdings as of 2025-12-31, filed 2026-08-21
This is history, not a current position. These holdings describe 2025-12-31, and the report became public 233 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
4
Value reported by manager
$171.3M
Sum of our stored positions
$171.3M
should match the line above
Disclosure lag
233 d
quarter end to filing
Top 5 concentration
100.0%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls
Positions
4 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| CYTOKINETICS, INC | COM | $62.3M | 980,392 | — | 23282W605 |
| ZENAS BIOPHARMA, INC. | COM | $45.9M | 1,263,150 | — | 98937L105 |
| BIOHAVEN LTD | COM | $33.2M | 2,936,507 | — | G1110E107 |
| BIOCRYST PHARMACEUTICALS INC | COM | $30M | 3,846,154 | — | 09058V103 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-21